The former boy band star was first treated for Type 2 diabetes before being diagnosed with Type 1.5 diabetes, also known as latent autoimmune diabetes in adults, and effectively reaping the benefits of Dexcom’s G7 continuous glucose monitor. More: ADA:
read moreA new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights significant gaps in the treatment experiences of people with metastatic colorectal cancer. More: Takeda survey finds colon cancer patients feel
read moreUnicycive has already lined up a second manufacturer after the FDA flagged deficiencies at a third-party vendor the company had hired to make its oxylanthanum carbonate (OLC) drug product. More: FDA hits Unicycive with manufacturing-related complete response letter, delaying hopes
read moreThe Orphan Cures Act has been added back into the Senate version of President Donald Trump’s “big, beautiful bill” after being left out in the chamber’s first rendition. More: Orphan Cures Act re-added to Trump tax bill as Senate prepares
read moreTwo weeks after Supernus Pharmaceuticals unveiled the proposed acquisition of Sage Therapeutics, all 338 employees from the latter company are being laid off, according to a Massachusetts Worker Adjustment and Retraining Notification. More: Sage lays off entire staff of 338
read more
Positive trial results offer hope for those with ultra-rare epileptic disorder More: UCB reports success in phase 3 study of fenfluramine for CDD Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals